Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > Here is an example of delisting extension

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Jan 30, 2023 3:51pm

77 Views

Post# 35254749

RE:Here is an example of delisting extension

Did you even read the article Rosenberg....the company is relying on a merger and an RS as justification for an extension....and what does FSD have to offer to justify an extention....another RS....is that on the table Rosenberg....you're an insider....ask your boss if that's the plan....to screw over investors again.....

DavidRosenberg wrote:

here's an example of a company that was able toacquire an additional 180 days extension on top of the first delisting notice they can issue a hearing panel to prolong to the listing process, so we still have a ways to go from that

Is the stock market anything is possible both positive and negative I'm just stating facts. Let's hope management is able to yield amazing results with any of the three clinical trials planned.

https://stocks.apple.com/AMJ1Wn5zXT3up5ONIvTwczw